Reid G. Adler

Overview

Reid G. Adler received an average of $614K in total compensation, including $411K in salary, at Vistagen Therapeutics between 2023 and 2024.

Source: SEC filings on April 15, 2024 and July 28, 2023.

Related executives

We found seven more executives who work or worked at Vistagen Therapeutics.

Shawn Singh

Vistagen Therapeutics

Chief Executive Officer

Joshua Prince

Vistagen Therapeutics

Chief Operating Officer

Cynthia Anderson

Vistagen Therapeutics

Chief Financial Officer

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

H Snodgrass

Vistagen Therapeutics

Chief Scientific Officer

Mark Smith

Vistagen Therapeutics

Chief Medical Officer

Mark McPartland

Vistagen Therapeutics

Vice President, Corporate Development

News

You may also like